PT  - JOURNAL ARTICLE
AU  - Vraga, Emily K
AU  - Brady, Sonya S
AU  - Gansen, Chloe
AU  - Khan, Euna M
AU  - Bennis, Sarah L.
AU  - Nones, Madalyn
AU  - Tang, Rongwei
AU  - Srivastava, Jaideep
AU  - Kulasingam, Shalini
TI  - HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19: A review
AID  - 10.1101/2023.01.25.23285015
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.01.25.23285015
4099  - http://medrxiv.org/content/early/2023/01/26/2023.01.25.23285015.short
4100  - http://medrxiv.org/content/early/2023/01/26/2023.01.25.23285015.full
AB  - Prior to the COVID-19 pandemic, the World Health Organization named vaccine hesitancy as one of the top 10 threats to global health. The impact of hesitancy on uptake of human papillomavirus (HPV) vaccines was of particular concern, given the markedly lower uptake compared to other adolescent vaccines in some countries, notably the United States. With the recent approval of COVID-19 vaccines coupled with the widespread use of social media, concerns regarding vaccine hesitancy have grown. However, the association between COVID-related vaccine hesitancy and cancer vaccines such as HPV is unclear. To examine the potential association, we performed two reviews using Ovid Medline and APA PsychInfo. Our aim was to answer two questions: (1) Is COVID-19 vaccine hesitancy, intention, or uptake associated with HPV or HBV vaccine hesitancy, intention, or uptake? and (2) Is exposure to COVID-19 vaccine misinformation on social media associated with HPV or HBV vaccine hesitancy, intention, or uptake? Our review identified few published empirical studies that addressed these questions. Our results highlight the urgent need for studies that can shift through the vast quantities of social media data to better understand the link between COVID-19 vaccine misinformation and disinformation and its impact on uptake of cancer vaccines.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding support for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no data associated with this manuscript.